These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1068 related articles for article (PubMed ID: 15308356)

  • 1. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies cell culture vaccines reconstituted and stored at 4 degrees C for 1 year prior to use protect mice against rabies virus.
    Lodmell DL; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3237-9. PubMed ID: 15308344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
    Wu X; Franka R; Henderson H; Rupprecht CE
    Vaccine; 2011 Jun; 29(25):4195-201. PubMed ID: 21514343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.
    Bouet-Cararo C; Contreras V; Fournier A; Jallet C; Guibert JM; Dubois E; Thiery R; Bréard E; Tordo N; Richardson J; Schwartz-Cornil I; Zientara S; Klonjkowski B
    Vaccine; 2011 Feb; 29(6):1304-10. PubMed ID: 21134446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and characterization of non-replicating recombinant vaccinia virus expressing rabies glycoprotein].
    Li P; Hu Q; Sun Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):170-4. PubMed ID: 12569788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts.
    Tantawichien T; Jaijaroensup W; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Nov; 33(10):E122-4. PubMed ID: 11641838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
    Wyatt LS; Earl PL; Eller LA; Moss B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of P gene-deficient rabies virus.
    Shoji Y; Inoue S; Nakamichi K; Kurane I; Sakai T; Morimoto K
    Virology; 2004 Jan; 318(1):295-305. PubMed ID: 14972555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
    McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
    J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
    Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
    Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.